CN Stock MarketDetailed Quotes

600671 Hangzhou Tianmushan Pharmaceutical Enterprise

Watchlist

8.26
-0.10-1.20%

Market Closed May 14 15:00 CST

1.01BMarket Cap-25812P/E (TTM)

Hangzhou Tianmushan Pharmaceutical Enterprise Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

(Q3)Mar 31, 2022

(FY)Dec 31, 2021

Assets

Current assets

Money funds

106.29%55.92M

131.08%97.96M

384.85%100.95M

-25.54%6.82M

100.42%27.11M

90.18%42.39M

-49.26%20.82M

-72.94%9.16M

333.68%13.53M

194.31%22.29M

Notes receivable and accounts receivable

29.82%39.94M

19.08%36.68M

-27.99%29.51M

-31.12%30.74M

-37.98%30.77M

-40.09%30.81M

-13.15%40.99M

-15.99%44.63M

-4.29%49.61M

17.20%51.42M

-Accounts receivable

29.82%39.94M

19.08%36.68M

-27.99%29.51M

-31.12%30.74M

-37.98%30.77M

-40.09%30.81M

-13.15%40.99M

-15.99%44.63M

-4.29%49.61M

17.20%51.42M

Other receivables (including interest and dividends)

18.53%2.13M

12.05%2M

-92.43%1.74M

-94.90%2.72M

-96.89%1.8M

-96.74%1.79M

-55.67%22.99M

-22.65%53.35M

-41.54%57.76M

-43.66%54.92M

-Other receivable

----

-94.90%2.72M

----

-96.74%1.79M

----

-22.65%53.35M

----

-43.66%54.92M

Advance payment

311.11%5.94M

7.89%1.1M

140.19%5.42M

45.90%4.99M

-68.38%1.44M

-68.21%1.02M

-38.37%2.26M

12.84%3.42M

-20.26%4.57M

-13.23%3.21M

Inventories

-7.84%45.36M

-9.70%42.95M

-26.97%41.85M

-13.31%47.05M

-6.04%49.22M

-9.16%47.56M

1.69%57.3M

1.14%54.27M

-16.51%52.38M

-22.45%52.36M

Receivable financing

-67.37%400.7K

50.53%277.4K

--1.28M

----

--1.23M

-54.52%184.29K

----

-15.32%405.2K

Other current assets

-22.32%688.21K

37.77%524.89K

-44.71%302.41K

30.16%564.35K

20.82%885.97K

-74.08%381.01K

-45.65%546.94K

-37.95%433.59K

-23.12%733.31K

-36.19%1.47M

Total current assets

33.73%150.38M

46.21%181.5M

24.96%181.06M

-43.80%92.89M

-37.03%112.45M

-33.29%124.13M

-28.61%144.9M

-23.21%165.27M

-20.77%178.58M

-16.53%186.08M

Non Current assets

Fixed assets

----

-20.52%142.32M

----

-16.74%154.24M

----

32.42%179.07M

----

33.60%185.26M

Constru in process

----

-95.16%416.86K

----

-98.72%110.03K

----

-86.17%8.62M

----

-85.98%8.62M

Intangible assets

-2.90%5.18M

-2.88%5.21M

-2.86%5.25M

-2.84%5.29M

-2.82%5.33M

-2.80%5.37M

-2.78%5.41M

-2.76%5.45M

-2.74%5.49M

-2.73%5.52M

Goodwill

----

-19.28%2.2M

-33.67%2.2M

-51.74%2.72M

-41.26%3.31M

Long deferred expense

1.26%2.2M

-11.25%2.2M

-65.66%1.45M

-60.62%1.92M

-58.61%2.17M

-58.26%2.48M

-29.00%4.23M

-17.01%4.89M

-19.36%5.25M

-12.83%5.93M

Deferred tax assets

152.88%1.83M

-36.26%2.2M

-63.49%724.28K

73.88%3.45M

58.09%1.98M

Usufruct assets

26.17%12.31M

12.11%11.87M

92.45%9.99M

99.21%10.84M

71.36%9.75M

78.08%10.58M

--5.19M

--5.44M

--5.69M

-30.97%5.94M

Other non current assets

--3.51M

----

Total non current assets

-5.51%162.3M

-7.65%164.79M

-21.89%159.38M

-21.35%163.72M

-19.12%171.76M

-17.61%178.43M

-5.50%204.04M

-3.59%208.16M

-1.41%212.36M

-5.06%216.57M

Total assets

10.02%312.68M

14.45%346.29M

-2.43%340.44M

-31.29%256.61M

-27.30%284.21M

-24.86%302.57M

-16.70%348.94M

-13.38%373.44M

-11.31%390.95M

-10.73%402.65M

Liabilities

Current liabilities

Short term loan

-30.67%72.45M

-1.91%102.64M

-1.91%102.5M

-0.04%104.58M

-1.42%104.5M

-1.97%104.64M

-1.98%104.5M

2.49%104.62M

-6.01%106.01M

-5.86%106.75M

Notes payable and accounts payable

39.22%65.05M

8.46%51.22M

-27.35%39.71M

-35.26%38.61M

-29.91%46.72M

-28.48%47.22M

-29.07%54.65M

-20.90%59.65M

-11.09%66.66M

-9.08%66.03M

-Notes payable

--6.55M

----

-Accounts payable

25.20%58.5M

8.46%51.22M

-27.35%39.71M

-35.26%38.61M

-29.91%46.72M

-28.48%47.22M

-29.07%54.65M

-20.90%59.65M

-11.09%66.66M

-9.08%66.03M

Contract liabilities

-3.76%3.81M

-5.40%3.39M

-42.75%3.34M

-55.01%2.96M

36.49%3.96M

19.68%3.58M

104.85%5.84M

128.56%6.57M

-7.00%2.9M

-13.95%2.99M

Salaries payable

-6.09%6.24M

-16.89%6.78M

-33.32%5.29M

-40.23%5.73M

11.90%6.64M

26.33%8.15M

12.79%7.93M

48.00%9.59M

-1.53%5.94M

11.50%6.45M

Taxs payable

170.65%3.84M

94.12%4.72M

5.88%2.15M

-15.61%1.79M

-43.51%1.42M

-40.26%2.43M

12.66%2.03M

-12.24%2.12M

-20.66%2.51M

10.77%4.07M

Other payable (including interest and dividends)

-12.91%42.99M

-8.91%46.27M

114.56%135.76M

-29.57%47.09M

-23.15%49.36M

-19.40%50.8M

10.40%63.27M

6.01%66.86M

17.40%64.23M

21.10%63.02M

-Dividend payable

0.00%23.4K

-Other payable

----

-29.58%47.07M

----

-19.40%50.78M

----

6.02%66.84M

----

21.11%63M

Non current liabilities due within one year

9.85%3.95M

25.58%4.9M

284.32%3.6M

209.87%3.6M

166.73%3.9M

103.56%936.58K

152.46%1.16M

-61.16%1.46M

Other current liabilities

11.59%489.48K

-5.15%464.42K

-42.16%433.2K

-55.05%383.68K

21.50%438.65K

31.10%489.64K

102.33%749.02K

128.65%853.61K

-34.41%361.04K

-12.90%373.49K

Total current liabilities

-8.23%198.81M

-0.38%220.38M

22.04%292.77M

-18.49%204.75M

-13.26%216.64M

-11.92%221.22M

-5.36%239.9M

-0.77%251.2M

-2.36%249.76M

-1.58%251.15M

Current liabilities

Estimate liabilities

-19.77%1.15M

-58.89%1.43M

-61.16%1.43M

155.46%3.48M

170.35%3.68M

Deferred tax liabilities

--2.97M

12.11%2.97M

----

--2.65M

----

Long term deferred income

-10.18%57.52M

-10.16%58.62M

-11.23%61.95M

-13.40%62.95M

-15.00%64.04M

-17.10%65.25M

-15.63%69.78M

-15.47%72.69M

-15.60%75.34M

-14.01%78.71M

Lease liabilities

-15.88%6.39M

-3.10%7.23M

39.97%6.66M

33.89%6.64M

63.51%7.59M

63.98%7.46M

--4.76M

--4.96M

--4.64M

-12.92%4.55M

Total non current liabilities

-6.90%68.02M

-8.89%69.96M

-10.23%70.03M

-12.46%71.02M

-12.67%73.06M

-11.68%76.79M

-11.82%78.02M

-11.57%81.13M

-11.96%83.66M

-15.20%86.94M

Total liabilities

-7.90%266.83M

-2.57%290.34M

14.12%362.8M

-17.02%275.77M

-13.11%289.7M

-11.86%298.01M

-7.03%317.92M

-3.65%332.33M

-4.96%333.42M

-5.48%338.09M

Shareholders equity

Paid-in capital

0.00%121.78M

Capital reserve funds

123.65%162.79M

10.79%72.79M

11.91%72.79M

4.45%65.7M

3.41%65.04M

Surplus reserve funds

0.00%24.18M

Retained profit

-16.05%-281.33M

-16.40%-271.61M

-33.04%-260.83M

-37.27%-256.8M

-41.24%-242.43M

-40.72%-233.34M

-29.72%-196.06M

-31.59%-187.07M

-23.41%-171.64M

-21.91%-165.82M

Shareholders equity without minority interests

215.76%27.42M

354.60%37.14M

-369.83%-42.09M

-254.74%-38.05M

-160.17%-23.68M

-132.28%-14.59M

-72.98%15.6M

-63.13%24.59M

-43.59%39.36M

-37.97%45.18M

Minority interests

1.36%18.43M

-1.75%18.81M

27.88%19.72M

14.34%18.88M

0.11%18.19M

-1.18%19.15M

-19.74%15.42M

-15.48%16.52M

-10.08%18.17M

-5.44%19.37M

Total shareholder equity

934.52%45.85M

1,127.18%55.95M

-172.08%-22.36M

-146.62%-19.16M

-109.55%-5.49M

-92.94%4.56M

-59.68%31.02M

-52.33%41.11M

-36.07%57.53M

-30.83%64.56M

Total liabilityies and equity

10.02%312.68M

14.45%346.29M

-2.43%340.44M

-31.29%256.61M

-27.30%284.21M

-24.86%302.57M

-16.70%348.94M

-13.38%373.44M

-11.31%390.95M

-10.73%402.65M

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion with explanatory notes

Adverse Opinion

Auditor

ZTE Finance Guanghua Certified Public Accountants (Special General Partnership)

	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022	(Q3)Mar 31, 2022	(FY)Dec 31, 2021
Assets
Current assets
Money funds	106.29%55.92M	131.08%97.96M	384.85%100.95M	-25.54%6.82M	100.42%27.11M	90.18%42.39M	-49.26%20.82M	-72.94%9.16M	333.68%13.53M	194.31%22.29M
Notes receivable and accounts receivable	29.82%39.94M	19.08%36.68M	-27.99%29.51M	-31.12%30.74M	-37.98%30.77M	-40.09%30.81M	-13.15%40.99M	-15.99%44.63M	-4.29%49.61M	17.20%51.42M
-Accounts receivable	29.82%39.94M	19.08%36.68M	-27.99%29.51M	-31.12%30.74M	-37.98%30.77M	-40.09%30.81M	-13.15%40.99M	-15.99%44.63M	-4.29%49.61M	17.20%51.42M
Other receivables (including interest and dividends)	18.53%2.13M	12.05%2M	-92.43%1.74M	-94.90%2.72M	-96.89%1.8M	-96.74%1.79M	-55.67%22.99M	-22.65%53.35M	-41.54%57.76M	-43.66%54.92M
-Other receivable	----	----	----	-94.90%2.72M	----	-96.74%1.79M	----	-22.65%53.35M	----	-43.66%54.92M
Advance payment	311.11%5.94M	7.89%1.1M	140.19%5.42M	45.90%4.99M	-68.38%1.44M	-68.21%1.02M	-38.37%2.26M	12.84%3.42M	-20.26%4.57M	-13.23%3.21M
Inventories	-7.84%45.36M	-9.70%42.95M	-26.97%41.85M	-13.31%47.05M	-6.04%49.22M	-9.16%47.56M	1.69%57.3M	1.14%54.27M	-16.51%52.38M	-22.45%52.36M
Receivable financing	-67.37%400.7K	50.53%277.4K	--1.28M	----	--1.23M	-54.52%184.29K	----	----	----	-15.32%405.2K
Other current assets	-22.32%688.21K	37.77%524.89K	-44.71%302.41K	30.16%564.35K	20.82%885.97K	-74.08%381.01K	-45.65%546.94K	-37.95%433.59K	-23.12%733.31K	-36.19%1.47M
Total current assets	33.73%150.38M	46.21%181.5M	24.96%181.06M	-43.80%92.89M	-37.03%112.45M	-33.29%124.13M	-28.61%144.9M	-23.21%165.27M	-20.77%178.58M	-16.53%186.08M
Non Current assets
Fixed assets	----	----	----	-20.52%142.32M	----	-16.74%154.24M	----	32.42%179.07M	----	33.60%185.26M
Constru in process	----	----	----	-95.16%416.86K	----	-98.72%110.03K	----	-86.17%8.62M	----	-85.98%8.62M
Intangible assets	-2.90%5.18M	-2.88%5.21M	-2.86%5.25M	-2.84%5.29M	-2.82%5.33M	-2.80%5.37M	-2.78%5.41M	-2.76%5.45M	-2.74%5.49M	-2.73%5.52M
Goodwill	----	----	-19.28%2.2M	-19.28%2.2M	-33.67%2.2M	-33.67%2.2M	-51.74%2.72M	-51.74%2.72M	-41.26%3.31M	-41.26%3.31M
Long deferred expense	1.26%2.2M	-11.25%2.2M	-65.66%1.45M	-60.62%1.92M	-58.61%2.17M	-58.26%2.48M	-29.00%4.23M	-17.01%4.89M	-19.36%5.25M	-12.83%5.93M
Deferred tax assets	152.88%1.83M	-36.26%2.2M	-63.49%724.28K	-63.49%724.28K	-63.49%724.28K	73.88%3.45M	58.09%1.98M	58.09%1.98M	58.09%1.98M	58.09%1.98M
Usufruct assets	26.17%12.31M	12.11%11.87M	92.45%9.99M	99.21%10.84M	71.36%9.75M	78.08%10.58M	--5.19M	--5.44M	--5.69M	-30.97%5.94M
Other non current assets	--3.51M	--3.51M	----	----	----	----	----	----	----	----
Total non current assets	-5.51%162.3M	-7.65%164.79M	-21.89%159.38M	-21.35%163.72M	-19.12%171.76M	-17.61%178.43M	-5.50%204.04M	-3.59%208.16M	-1.41%212.36M	-5.06%216.57M
Total assets	10.02%312.68M	14.45%346.29M	-2.43%340.44M	-31.29%256.61M	-27.30%284.21M	-24.86%302.57M	-16.70%348.94M	-13.38%373.44M	-11.31%390.95M	-10.73%402.65M
Liabilities
Current liabilities
Short term loan	-30.67%72.45M	-1.91%102.64M	-1.91%102.5M	-0.04%104.58M	-1.42%104.5M	-1.97%104.64M	-1.98%104.5M	2.49%104.62M	-6.01%106.01M	-5.86%106.75M
Notes payable and accounts payable	39.22%65.05M	8.46%51.22M	-27.35%39.71M	-35.26%38.61M	-29.91%46.72M	-28.48%47.22M	-29.07%54.65M	-20.90%59.65M	-11.09%66.66M	-9.08%66.03M
-Notes payable	--6.55M	----	----	----	----	----	----	----	----	----
-Accounts payable	25.20%58.5M	8.46%51.22M	-27.35%39.71M	-35.26%38.61M	-29.91%46.72M	-28.48%47.22M	-29.07%54.65M	-20.90%59.65M	-11.09%66.66M	-9.08%66.03M
Contract liabilities	-3.76%3.81M	-5.40%3.39M	-42.75%3.34M	-55.01%2.96M	36.49%3.96M	19.68%3.58M	104.85%5.84M	128.56%6.57M	-7.00%2.9M	-13.95%2.99M
Salaries payable	-6.09%6.24M	-16.89%6.78M	-33.32%5.29M	-40.23%5.73M	11.90%6.64M	26.33%8.15M	12.79%7.93M	48.00%9.59M	-1.53%5.94M	11.50%6.45M
Taxs payable	170.65%3.84M	94.12%4.72M	5.88%2.15M	-15.61%1.79M	-43.51%1.42M	-40.26%2.43M	12.66%2.03M	-12.24%2.12M	-20.66%2.51M	10.77%4.07M
Other payable (including interest and dividends)	-12.91%42.99M	-8.91%46.27M	114.56%135.76M	-29.57%47.09M	-23.15%49.36M	-19.40%50.8M	10.40%63.27M	6.01%66.86M	17.40%64.23M	21.10%63.02M
-Dividend payable	0.00%23.4K	0.00%23.4K	0.00%23.4K	0.00%23.4K	0.00%23.4K	0.00%23.4K	0.00%23.4K	0.00%23.4K	0.00%23.4K	0.00%23.4K
-Other payable	----	----	----	-29.58%47.07M	----	-19.40%50.78M	----	6.02%66.84M	----	21.11%63M
Non current liabilities due within one year	9.85%3.95M	25.58%4.9M	284.32%3.6M	284.32%3.6M	209.87%3.6M	166.73%3.9M	103.56%936.58K	103.56%936.58K	152.46%1.16M	-61.16%1.46M
Other current liabilities	11.59%489.48K	-5.15%464.42K	-42.16%433.2K	-55.05%383.68K	21.50%438.65K	31.10%489.64K	102.33%749.02K	128.65%853.61K	-34.41%361.04K	-12.90%373.49K
Total current liabilities	-8.23%198.81M	-0.38%220.38M	22.04%292.77M	-18.49%204.75M	-13.26%216.64M	-11.92%221.22M	-5.36%239.9M	-0.77%251.2M	-2.36%249.76M	-1.58%251.15M
Current liabilities
Estimate liabilities	-19.77%1.15M	-19.77%1.15M	-58.89%1.43M	-58.89%1.43M	-61.16%1.43M	-61.16%1.43M	155.46%3.48M	155.46%3.48M	170.35%3.68M	170.35%3.68M
Deferred tax liabilities	--2.97M	12.11%2.97M	----	----	----	--2.65M	----	----	----	----
Long term deferred income	-10.18%57.52M	-10.16%58.62M	-11.23%61.95M	-13.40%62.95M	-15.00%64.04M	-17.10%65.25M	-15.63%69.78M	-15.47%72.69M	-15.60%75.34M	-14.01%78.71M
Lease liabilities	-15.88%6.39M	-3.10%7.23M	39.97%6.66M	33.89%6.64M	63.51%7.59M	63.98%7.46M	--4.76M	--4.96M	--4.64M	-12.92%4.55M
Total non current liabilities	-6.90%68.02M	-8.89%69.96M	-10.23%70.03M	-12.46%71.02M	-12.67%73.06M	-11.68%76.79M	-11.82%78.02M	-11.57%81.13M	-11.96%83.66M	-15.20%86.94M
Total liabilities	-7.90%266.83M	-2.57%290.34M	14.12%362.8M	-17.02%275.77M	-13.11%289.7M	-11.86%298.01M	-7.03%317.92M	-3.65%332.33M	-4.96%333.42M	-5.48%338.09M
Shareholders equity
Paid-in capital	0.00%121.78M	0.00%121.78M	0.00%121.78M	0.00%121.78M	0.00%121.78M	0.00%121.78M	0.00%121.78M	0.00%121.78M	0.00%121.78M	0.00%121.78M
Capital reserve funds	123.65%162.79M	123.65%162.79M	10.79%72.79M	10.79%72.79M	11.91%72.79M	11.91%72.79M	4.45%65.7M	4.45%65.7M	3.41%65.04M	3.41%65.04M
Surplus reserve funds	0.00%24.18M	0.00%24.18M	0.00%24.18M	0.00%24.18M	0.00%24.18M	0.00%24.18M	0.00%24.18M	0.00%24.18M	0.00%24.18M	0.00%24.18M
Retained profit	-16.05%-281.33M	-16.40%-271.61M	-33.04%-260.83M	-37.27%-256.8M	-41.24%-242.43M	-40.72%-233.34M	-29.72%-196.06M	-31.59%-187.07M	-23.41%-171.64M	-21.91%-165.82M
Shareholders equity without minority interests	215.76%27.42M	354.60%37.14M	-369.83%-42.09M	-254.74%-38.05M	-160.17%-23.68M	-132.28%-14.59M	-72.98%15.6M	-63.13%24.59M	-43.59%39.36M	-37.97%45.18M
Minority interests	1.36%18.43M	-1.75%18.81M	27.88%19.72M	14.34%18.88M	0.11%18.19M	-1.18%19.15M	-19.74%15.42M	-15.48%16.52M	-10.08%18.17M	-5.44%19.37M
Total shareholder equity	934.52%45.85M	1,127.18%55.95M	-172.08%-22.36M	-146.62%-19.16M	-109.55%-5.49M	-92.94%4.56M	-59.68%31.02M	-52.33%41.11M	-36.07%57.53M	-30.83%64.56M
Total liabilityies and equity	10.02%312.68M	14.45%346.29M	-2.43%340.44M	-31.29%256.61M	-27.30%284.21M	-24.86%302.57M	-16.70%348.94M	-13.38%373.44M	-11.31%390.95M	-10.73%402.65M
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	--	--	Unqualified opinion with explanatory notes	--	--	--	Adverse Opinion
Auditor	--	--	--	--	--	ZTE Finance Guanghua Certified Public Accountants (Special General Partnership)	--	--	--	ZTE Finance Guanghua Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

600671 Hangzhou Tianmushan Pharmaceutical Enterprise

Hangzhou Tianmushan Pharmaceutical Enterprise Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target